1,2,3,4-tetrahydroquinoline has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, AM; Chen, L; Fletcher, S; Wilder, PT | 1 |
| Auld, DS; Bougie, JM; Boxer, MB; Brimacombe, KR; Cantley, LC; Daniel, T; Israelsen, WJ; Leister, W; Shen, M; Thomas, CJ; Vander Heiden, MG; Veith, H; Walsh, MJ | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Neoplasms
| Article | Year |
|---|---|
1-Sulfonylated 1,2,3,4-tetrahydroquinoline-6-carboxylic acids as simple, readily-accessible MCL-1 inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Carboxylic Acids; Cell Line, Tumor; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Quinolines | 2022 |
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Topics: Alternative Splicing; Caco-2 Cells; Enzyme Activators; Humans; Isoenzymes; Neoplasms; Pyruvate Kinase; Quinolines | 2011 |